-
公开(公告)号:CS347091A3
公开(公告)日:1992-06-17
申请号:CS347091
申请日:1991-11-15
Applicant: HOECHST AG
IPC: A61K31/41 , A61K31/415 , A61K31/42 , A61K31/425 , A61K31/495 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/02 , A61P15/00 , A61P43/00 , C07D233/64 , C07D233/68 , C07D233/70 , C07D233/88 , C07D249/04 , C07D249/08 , C07D257/04 , C07D403/10 , C07D403/14 , C07D405/10 , C07D409/10 , C07D411/10 , C07D413/10 , C07D207/325 , C07D231/12 , A61K31/40
Abstract: Azoles of the formula in which X, Y and Z represent N or CR , L denotes alkylene, A denotes an aromatic or heterocyclic radical and T denotes a bond or a bivalent radical and R , R and E are as defined in the description. A process for their preparation, compositions containing these compounds and their application as medicines are also described.
-
公开(公告)号:CS368890A3
公开(公告)日:1992-02-19
申请号:CS368890
申请日:1990-07-24
Applicant: HOECHST AG
Inventor: KLEEMANN HEINZ-WERNER DR , URBACH HANSJORG DR , WAGNER ADALBERT DR , RUPPERT DIETER DR , LINZ WOLFGANG DR , KRAMES WERNER DR
IPC: C12N9/99 , A61K31/38 , A61K31/381 , A61K31/415 , A61K31/445 , A61K31/535 , A61K38/55 , A61P9/12 , C07C237/08 , C07C237/22 , C07D211/26 , C07D211/58 , C07D233/54 , C07D233/64 , C07D295/20 , C07D333/24 , C07D401/12 , C07D403/12 , C07D409/12 , C07D521/00 , C07K1/113 , C07K5/06 , C07K5/065 , C07K5/078 , C07K14/81
Abstract: The present invention relates to compounds of the formula I in which A, R , R , R and n are defined as indicated in the description, to processes for the preparation thereof, to the use thereof as medicines and to pharmaceutical compositions containing these.
-
公开(公告)号:DE3932817A1
公开(公告)日:1991-04-11
申请号:DE3932817
申请日:1989-09-30
Applicant: HOECHST AG
Inventor: KLEEMANN HEINZ-WERNER DR , URBACH HANSJOERG DR , WAGNER ADALBERT DR , RUPPERT DIETER DR , LINZ WOLFGANG DR , KRAMER WERNER DR DR
IPC: C07D233/54 , C07D401/12 , C07D403/12 , C07D409/12 , C07K5/065 , C07K5/078
Abstract: Peptide polyhydroxyalkylamides of formula (I) and their salts are new; where A = R1R6N-CHR5-CO-, R1R7CH-CHR5-CO- or R1O-CHR5-CO-; R1 = R'1 or R'1W; R'1 = (a) 3-8C cycloalkyl, CONH2, OCH2COOH, NH2, etc. (b) H, OH or 1-4C alkoxy, (c) 1-18C alkyl, quanidino, phenyl(1-4C)alkoxy, etc. (d) 6-14C aryl, (6-14C)aryl(1-4C)alkyl, etc. (e) Het or Het(1-4C)alkyl, where Het is an opt. benzo-fused 5- to 7-membered heterocyclic ring contg. 1 or 2 of N, O, S, No, etc. (f) NR8R9; Het or Het(1-4C)alkyl, or NR8R9 is a mono- or bicyclic 5- to 12-membered ring system opt. contg. 1 or 2 more N atoms, an S atom or an O atom, opt. substd. by 1-4C alkyl; W = CO, CS, OSO, SO2, SO, NHSO2, NHCO, CHOH or NOH; n = 2-10.
-
公开(公告)号:DE3836911A1
公开(公告)日:1989-05-24
申请号:DE3836911
申请日:1988-10-29
Applicant: HOECHST AG
Inventor: KLEEMANN HEINZ-WERNER DR , URBACH HANSJOERG DR , RUPPERT DIETER DR , SCHOELKENS BERNWARD DR
Abstract: The invention relates to compounds of the formula I in which A is one of the radicals of the formulae or A is absent or is a radical of the formula R , R and R are defined as in the description, and X and Y are, independently of one another, -O- or -NR , and their salts. Also described are a process for the preparation of the compounds of the formula I, corresponding pharmaceutical products and their use as medicines as well as intermediates for the preparation of these compounds.
-
公开(公告)号:DE3610593A1
公开(公告)日:1987-10-01
申请号:DE3610593
申请日:1986-03-29
Applicant: HOECHST AG
Inventor: WEGMANN HELMUT DR , WAGNER ADALBERT DR , KLEEMANN HEINZ-WERNER DR , RUPPERT DIETER DR
IPC: C07K14/81 , A61K31/165 , A61K31/18 , A61K31/195 , A61K31/215 , A61K31/22 , A61K31/235 , A61K31/255 , A61K31/27 , A61P9/12 , A61P43/00 , C07C67/00 , C07C231/00 , C07C231/02 , C07C231/12 , C07C237/06 , C07C237/12 , C07C237/20 , C07C237/22 , C07C239/00 , C07C301/00 , C07C303/30 , C07C303/36 , C07C309/76 , C07C311/37 , C07C313/00 , C07C317/48 , C07C317/50 , C07C323/41 , C07D213/38 , C07D233/54 , C07D233/61 , C07D233/64 , C07D521/00 , C07K1/113 , C07K5/02 , C07K5/06 , A61K37/64 , C07D213/40
-
公开(公告)号:MY117500A
公开(公告)日:2004-07-31
申请号:MYPI9801407
申请日:1998-03-30
Applicant: HOECHST AG
Inventor: WEICHERT ANDREAS DR , BRENDEL JOACHIM DR , KLEEMANN HEINZ-WERNER DR , LANG HANS JOCHEN DR , SCHWARK JAN-ROBERT DR , ALBUS UDO DR , SCHOLZ WOLFGANG DR
IPC: A61K31/155 , C07C279/22 , A61K31/165 , A61P3/06 , A61P9/00 , A61P9/06 , A61P9/10 , A61P11/00 , A61P13/02 , A61P15/00 , A61P25/00 , A61P35/00 , C07C279/10 , C07C279/20
Abstract: BENZOYLGUANIDINES OF FORMULA I IWITH R(1) TO R(4) AS DEFINED IN THE SPECIFICATION, ARE SUITABLE AS ANTIARRHYTHMIC PHARMACEUTICALS HAVING A CARDIOPROTECTIVE COMPONENT FOR INFARCT PROPHYLAXIS AND INFARCT TREATMENT AS WELL AS FOR THE TREATMENT OF ANGINA PECTORIS. THEY INHIBIT, IN A PREVENTIVE MANNER, THE PATHOPHYSIOLOGICAL PROCESSES IN THE FORMATION OF ISCHEMICALLY INDUCED DAMAGE, IN PARTICULAR IN THE ELICITATION OF ISCHEMICALLY INDUCED CARDIAC ARRHYTHMIAS.
-
公开(公告)号:AT248817T
公开(公告)日:2003-09-15
申请号:AT95105088
申请日:1995-04-05
Applicant: HOECHST AG
Inventor: KLEEMANN HEINZ-WERNER DR , LANG HANS-JOCHEN DR , SCHWARK JAN-ROBERT DR , WEICHERT ANDREAS DR , SCHOLZ WOLFGANG DR , ALBUS UDO DR
IPC: A01N1/02 , A61K31/34 , A61K31/341 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/4015 , A61K31/4025 , A61K31/415 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/445 , A61K31/47 , A61K49/00 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , A61P9/12 , A61P11/00 , A61P13/02 , A61P15/00 , A61P25/28 , A61P35/00 , C07D207/34 , C07D207/40 , C07D207/416 , C07D307/68 , C07D333/38 , C07D333/48 , C07D401/12 , C07D403/04 , C07D403/12 , C07D405/04 , C07D405/12 , C07D409/04 , C07D409/12
Abstract: Heteroaryl-guanidine derivs. of formula (I) and their salts are new. A = S(O)m, O or NR5; m = 0, 1 or 2; R5 = H, 1-8C alkyl or CmH2mR81; R81 = 3-8C cycloalkyl, phenyl (opt. substd. by 1-3 of F, Cl, CF3, Me, OMe, and NR82R83) or 1-9C heteroaryl (bonded via C or N and opt. substd. by 1-3 of F, Cl, CF3, Me, OMe, OH, NH2, NHMe and NMe2); R82, R83 = H or Me; one of R1, R2 = CO-N=C(NH2)2; the other = H, F, Cl, Br, I, 1-3C alkyl, OR6, 1-4C perfluoroalkyl, CO-N=C(NH2)2 or NR6R7; R6,R7 = H or 1-3C alkyl; R3, R4 = (i) H, F, Cl, Br, I, CN, X(CH2)m(1-6C) perfluoroalkyl, X(CH2)mF, S(O)mR8, CONR9R10, COR11, SO2NR12R13; (ii) 1-8C alkyl, CmH2mR81; (iii) 1-9C heteroaryl (opt. substd. by 1-3 of F, Cl, CF3, Me, OMe, OH, NH2, NHMe and NMe2); (iv) -Y-C6H4-(CO)i-(CHOH)j-(CHOH)k-R23; (v) H, F, Cl, Br, I, CN, 1-8C alkyl, 1-8C perfluoralkyl, 3-8C alkenyl, CgH2g-R26; SR29, OR30, NR31R32, CR33R34R35; (vii) -W-C6H4-R97; (viii) S(O)mR37, SO2NR38R39; (ix) X1R46; (x) SR64, OR65, NHR66, NR67R68, CHR_R69R70, CR54R55-OH, C IDENTICAL C-R56 C(R58) C-R57 (sic), (CR59R60)u-CO-(CR61R62)v-R63; (xi) SO2NHR76; or (xii)NR84R85; X = O, S or NR14; R14 = H or 1-3C alkyl; R8 = 1-5C alkyl, 3-6C alkenyl, CnH2nR15 or CF3; R9, R11, R12 = H or as R8; n = 0-4; R15 = 3-7C cycloalkyl or phenyl (opt. substd. by 1-3 of F, Cl, CF3, Me, OMe and NR16R17); R16,R17 = H or 1-4C alkyl; R10, R13 = H or 1-4C alkyl; or R9+R10 or R12+R13 = (CH2)4 or (CH2)5 in which one CH2 may be replaced by O, S, NH, NMe or N-benzyl; R18 = 3-8C cycloalkyl or phenyl (opt. substd. by 1-3 of F, Cl, CF3, Me, OMe and NR19R20); R19,R20 = H or Me; Y = O, S or NR22; h = 0 or 1; i, j, k = 0-4; provided that h, i and k are not all 0; R22,R23 = H or 1-3C alkyl; g = 0-4; R26 = 3-8C cycloalkyl, phenyl, biphenyl, or naphthyl (where aromatics are opt. substd. by 1-3 of F, Cl, CF3, Me, OMe and NR27R28); R27,R28 = H, 1-4C alkyl or 1-4C perfluoroalkyl; R29-R31, R33 = -(CH2)m- (1-9C) heteroaryl (opt. substd. as in R81); R32, R34 , R35 = H, 1-4C alkyl, 1-4C perfluoroalkyl, or as R29; R96 = heteroaryl as defined for R81, or benzyl; W = O, S or NR36; R36 = H or 1-4C alkyl; R37 = 1-8C alkyl, 1-8C perfluoroalkyl, 3-8C alkenyl or -CsH2s-R40; s = 0-4; R40 = as R26; R38 = H, 1-8C alkyl, 1-8C perfluoroalkyl, 3-8C alkenyl or -CwH2w-R26; R39 = H, 1-4C alkyl or 1-4C perfluoroalkyl; or R38+R39 = (CH2)4 or (CH2)5, in which one CH2 may be replaced by O, S, NH, NMe or N-benzyl; X1 = O, S, NR47, (D=O)A'- or NR48C=MN*(R49)-; M = O or S; A' = O or NR50; D = C or SO; R46, R49 = 1-8C alkyl, 3-8C alkenyl, -(CH2)b-(1-7C)perfluoroalkyl or -CxH2x-R26; b = 0 or 1; x = 0-4; R47, R48, R50 = H, 1-4C alkyl or 1-4C perfluoroalkyl; or R46+R47 or R46+R48 = (CH2)4 or (CH2)5 in which CH2 may be replaced by O, S, NH, NMe or N-benzyl; A' and N* are bonded to the phenyl ring of the benzoylguanidine structure; R64-R67, R69 = -(CH2)y-(CHOH)z-(CH2)q'-(CH2OH)t-R71 or -(CH2)b'-O-(CH2CH2O)c'-R72; R71, R72 = H or Me; b', c' are not defined; u, t = 1-4; v, y, z, a' = 0-4; R68, R70, R54, R55 = H or 1-6C alkyl; or CR69R70 or CR54R55 = 3-8C cycloalkylidene; R63 = H, 1-6C alkyl, 3-8C cycloalkyl or -CeH2e-R73; e = 0-4; R80 = 5-7C cycloalkyl or phenyl (opt. substd. by 1-3 of F, Cl, CF3, OMe and 1-4C alkyl); or R77+R78 = (CH2)4 or (CH2)5, in which one CH2 may be replaced by O, S, NH, NMe or N-benzyl; R79 = as R77; or amidino; R84, R85 = H or 1-4C alkyl; or R84+R85 = (CH2)4 or (CH2)5 in which one CH2 may be replaced by O, S, NH, NMe or N-benzyl or 1 or 2 CH2 gps. may be replaced by CH-Cd_'H2d'+1; d' is not defined. Cpds. (I; A = O; R1 = -CON=C(NH2)2; R2, R3 = H; R4 = H, Me or Et) are excluded.
-
公开(公告)号:AT247644T
公开(公告)日:2003-09-15
申请号:AT92115500
申请日:1992-09-10
Applicant: HOECHST AG
Inventor: HEITSCH HOLGER DR , WAGNER ADALBERT DR , KLEEMANN HEINZ-WERNER DR , GERHARDS HERMANN DR , SCHOELKENS BERNWARD PROF DR
IPC: A61K31/33 , A61K31/415 , A61K31/4184 , A61K31/435 , A61K31/4375 , A61K31/44 , A61K31/495 , A61K31/505 , A61P9/10 , A61P9/12 , C07D235/06 , C07D235/08 , C07D235/22 , C07D235/24 , C07D403/10 , C07D409/06 , C07D471/04 , C07D487/04 , C07D519/00
Abstract: Compounds of the formula (I) in which the symbols have the following meaning: X represents a monocyclic radical having 3, 4 or 5 ring atoms, R , R , R , R , R , R and R is, for example, an alkyl radical q is zero or 1 L is, for example, the methylene group A is the radical, for example, of a heterocycle are highly effective as antagonists of angiotensin II receptors. They can be used as pharmaceuticals or diagnostics.
-
公开(公告)号:HU222524B1
公开(公告)日:2003-08-28
申请号:HU9403759
申请日:1994-12-22
Applicant: HOECHST AG
Inventor: ALBUS UDO DR , KLEEMANN HEINZ-WERNER DR , LANG HANS-JOCHEN DR , SCHOLZ WOLFGANG DR , SCHWARK JAN-ROBERT DR , WEICHERT ANDREAS DR
IPC: C07D217/26 , A61K31/47 , A61K31/472 , A61K31/54 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , C07C233/65 , C07C235/84 , C07C311/16 , C07D213/46 , C07D217/24 , C07D279/02
Abstract: There are described acylguanidines I where X is carbonyl or sulphonyl; R(1) is H, (cyclo)alkyl, phenyl; R(2) is H, alkyl, and their pharmaceutically tolerable salts. They are obtained by reaction of a compound II with guanidine. The compounds have no undesired salidiuretic properties, but have very good antiarrhythmic properties. As a result of inhibition of the cellular Na /H exchange mechanism, they can be used for the treatment of all acute or chronic injuries induced by ischaemia.
-
公开(公告)号:CZ291848B6
公开(公告)日:2003-06-18
申请号:CZ188797
申请日:1997-06-17
Applicant: HOECHST AG
Inventor: WEICHERT ANDREAS DR , BRENDEL JOACHIM DR , KLEEMANN HEINZ-WERNER DR , LANG HANS JOCHEN DR , SCHWARK JAN-ROBERT DR , ALBUS UDO DR , SCHOLZ WOLFGANG DR
IPC: A61K31/165 , A01N1/02 , A01N47/44 , A61K31/10 , A61K31/155 , A61K31/18 , A61P3/06 , A61P3/10 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , A61P35/00 , A61P43/00 , C07C279/10 , C07C279/20 , C07C279/22 , C07C303/40 , C07C311/19 , C07C311/47 , C07C317/42 , C07C317/50
Abstract: In the present invention, there are disclosed benzoylguanidines of the general formula I, in which Re1 through Re4 have meanings indicated in the claims. These compounds are valuable antiarrhythmic medicaments with a cardioprotective component, suitable also for prevention of ischemia-induced lesions, in particular of ischemia induced heart arrhythmias. They are because of inhibition of Nae+/He+ cell exchange mechanism for treating acute lesions induced by ischemia. In addition, thereto, they exhibit a strong inhibition activity on cell proliferation. They are further suitable for preventing blood hypertension.
-
-
-
-
-
-
-
-
-